Organon and Co. (NYSE: OGN - Get Free Report) and Ardent Health (NYSE: ARDT - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companie
Organon (OGN) concluded the recent trading session at $7.44, signifying a +2.76% move from its prior day's close.
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in Organon and Co. (NYSE: OGN) by 65.2% during the undefined quarter, according to the company in its most recent 13F filing with the Sec
Gilman Hill Asset Management LLC lessened its holdings in shares of Organon and Co. (NYSE: OGN) by 87.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the latest trading session, Organon (OGN) closed at $6.98, marking a +2.2% move from the previous day.
Squarepoint Ops LLC acquired a new stake in Organon and Co. (NYSE: OGN) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fu
VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce an exploration update on the Ermitaño gold mine
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to note Kodiak Copper Corp.'s (TSX.V:KDK) ("Kodiak") announce
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Brandes Investment Partners LP grew its stake in Organon and Co. (NYSE: OGN) by 77.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 398,423 shares of
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Creative Planning grew its stake in shares of Organon and Co. (NYSE: OGN) by 109.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange C
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's Interim CEO Joe Morrissey and CFO Matthew Walsh to participate in fireside chat at Piper Sandler Annual Healthcare Conference on December 3.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE